By immunohistochemistry, MYC (84% vs. 24%) and BCL6 (77% vs. 16%) expression were significantly more frequent in blastoid HGBL cases than B-ALL (p < 0.0001, Table 1 and Figure 1). This evidence concerns the gene BCL6 and acute lymphoblastic leukemia.